News

August 2, 2016August 2, 2016

ARA 290 for Pancreatic Islet Cell Transplant Granted Fourth Orphan Designation

News

The US Food and Drug Administration (FDA) has granted the fourth Orphan Drug Designation to Araim Pharmaceuticals’ ARA 290, an innate repair receptor (IRR) activator for increased survival and improved function of pancreatic islets after ... Read more

July 29, 2016July 29, 2016

New Type 2 Diabetes Treatment, Adlyxin, Approved for Use in US

News, Type 2 Diabetes News

The U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide) as a new treatment for type 2 diabetes this week. The treatment consists of a daily injection that, combined with ... Read more

July 27, 2016July 27, 2016

Type 2 Diabetes May Result From Deficient Activity by Special Pancreatic Beta-cells

insulin resistance, News, Type 2 Diabetes News

Insulin released by pancreatic beta (β) cells regulates blood glucose levels. If the system fails, it may cause hyperglycemia inducing Type 2 diabetes. But recent research indicates that a specific subset ... Read more

July 25, 2016July 26, 2016

Type 2 Diabetes Patients Willing to Reach Targets More Than Doctors Think

News

The American Association of Clinical Endocrinologists (AACE) recently reported results from two online surveys that included 1,000 adults with type 2 diabetes (T2D), diagnosed one to five years ago, and 1,004 physicians. ... Read more

July 22, 2016July 22, 2016

Diabetics Hospitalized for Hypoglycemia in England Rises by 39% in Decade

News

Hospital admissions in England for short-term and preventable complications associated with diabetes — specifically, a dangerous drop in blood sugar levels — have increased by 39 percent in the last ... Read more

July 20, 2016July 20, 2016

FDA Expands Use for Synjardy to Type 2 Diabetes Treatment for First Time Adults

News, Type 2 Diabetes News

Boehringer Ingelheim’s and Eli Lilly and Company’s joint product, Synjardy (empagliflozin and metformin hydrochloride,) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication to include treatment-naïve ... Read more

July 18, 2016July 18, 2016

Study Shows Cholesterol-Lowering Drug May Benefit Diabetes Patients

News, Type 1 Diabetes News, Type 2 Diabetes News

Scientists may be one step closer to understanding the reason why simvastatin, a drug normally used to lower cholesterol, is also beneficial for inflammatory diseases such as diabetes.

July 15, 2016July 15, 2016

Possible Diabetes Therapy to Be Tested in Rare, Females-only Study

News

It is generally assumed, in health-related research, that males and females of a given species respond to a specific drug in much the same way. This is why preclinical studies in ... Read more

July 13, 2016July 13, 2016

Beneficial Effects of Relamorelin for Diabetes Stomach Problems Fail to Impress Several Experts

News

Rhythm Pharmaceuticals’ investigational drug relamorelin speeds up the passage of food through the stomach and reduces vomiting in adult patients with diabetic gastroparesis — a condition slowing the movement of ... Read more

July 6, 2016July 6, 2016

Diabetic Foot Ulcer Cells Can Be Reprogrammed into Embryonic-like Cells, Researchers Find

News

Researchers at Tufts University School of Dental Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have reprogrammed non-healing skin cells from diabetic foot ulcers into pluripotent stem cells. ... Read more